about
Silencing mutant ataxin-3 rescues motor deficits and neuropathology in Machado-Joseph disease transgenic miceRNA interference mitigates motor and neuropathological deficits in a cerebellar mouse model of Machado-Joseph diseaseAssociation study of common polymorphisms in MSRA, TFAP2B, MC4R, NRXN3, PPARGC1A, TMEM18, SEC16B, HOXB5 and OLFM4 genes with obesity-related traits among Portuguese children.Current review of genetics of human obesity: from molecular mechanisms to an evolutionary perspective.Polymorphisms in the SNRPN gene are associated with obesity susceptibility in a Spanish population.Association of FTO polymorphisms with obesity and obesity-related outcomes in Portuguese childrenSLC40A1 Q248H allele frequencies and associated SLC40A1 haplotypes in three West African population samples.Re-establishing ataxin-2 downregulates translation of mutant ataxin-3 and alleviates Machado-Joseph disease.Influence of TFAP2B and KCTD15 genetic variability on personality dimensions in anorexia and bulimia nervosa.The contribution of genetics and environment to obesity.Distribution of the - 13910C>T polymorphism in the general population of Portugal and in subjects with gastrointestinal complaints associated with milk consumption.Overexpression of mutant ataxin-3 in mouse cerebellum induces ataxia and cerebellar neuropathology.Assessment of obesity and abdominal obesity among Portuguese children.Beclin 1 mitigates motor and neuropathological deficits in genetic mouse models of Machado-Joseph disease.The effect of copy number variations in chromosome 16p on body weight in patients with intellectual disabilityPhysical activity and the association between the FTO rs9939609 polymorphism and obesity in Portuguese children aged 3 to 11 yearsGenetic screening for MC4R gene identifies three novel mutations associated with severe familiar obesity in a cohort of Spanish individuals
P50
Q27324749-5205555E-6B3B-4D1E-864B-8CC13E09A044Q34075342-F2F8F5DD-76D5-4D1A-9671-3A83156B50A8Q34412143-729A2A3B-54AA-4086-A61F-D7A73B6636C2Q34466165-8F1E64B9-55EB-4971-97A2-0F1343C7504BQ34554940-739286EE-526A-4ED8-B4A2-4519BD1456BEQ34559391-2D3A9D83-C9A5-40F7-9411-B46A023D9EC5Q38867755-67D90059-D234-4F0A-A21D-0F0DBBA1D2F3Q41195414-54FE388F-79D0-48E1-9D74-DFC97379722BQ41691377-D9EEFC09-C127-4F22-9F9C-A57F43D241E9Q41997918-3894D0D3-A8F8-4AE4-9DCC-03B860189AE5Q44646665-B4B2C71D-35DC-472F-A52A-5442D83D078DQ45349098-6C6E11CE-C4F4-4416-A68C-3CFA6A0BAE56Q47822561-541BEF6A-0E23-4391-AF93-565546C5ADF4Q50478273-F1E81B8D-9BB1-4E38-A2C4-61CA96B4C6E3Q90288872-D9E44599-7A42-42BA-97C0-1B4F72255AE3Q92837803-9C5EEBE8-0C25-42AA-8A9A-9A62BAE37695Q93076115-95CC2861-9439-4616-9543-4609CD5F9650
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
David Albuquerque
@ast
David Albuquerque
@en
David Albuquerque
@es
David Albuquerque
@nl
type
label
David Albuquerque
@ast
David Albuquerque
@en
David Albuquerque
@es
David Albuquerque
@nl
prefLabel
David Albuquerque
@ast
David Albuquerque
@en
David Albuquerque
@es
David Albuquerque
@nl
P106
P1153
45260981900
P21
P31
P496
0000-0001-8899-9020